Navitor
Device Vascular
PDI 05415067045805
General payments
$1,278,922
Research payments
$1,633,537
Through program year 2025, $1,278,922 in general payments and $1,633,537 in research payments were reported against Navitor (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $100,392 | 219 |
| 2024 | General | $959,669 | 3,017 |
| 2024 | Research | $1,559,856 | 511 |
| 2023 | General | $218,860 | 989 |
| 2023 | Research | $73,681 | 66 |
Breakdown
The top 5 of 25 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,225 general · 577 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.